Literature DB >> 8627713

Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro.

A Nihrane1, K Fujita, R Willey, M S Lyu, J Silver.   

Abstract

Transgenic mice bearing a murine retroviral envelope transgene (Fv4) have Fv4 gp70env (SU) in their serum in amounts sufficient to block infection by ecotropic virus in vitro. Fv4 Env in serum is derived largely but not exclusively from hematopoietic cells. Tail cells from Fv4 mice and cell lines transduced with the Fv4 env transgene synthesize both components of the envelope protein (gp70 SU and p15E TM) but secrete the gp70 moiety, in the absence of retroviral particles. Blocking of the ecotropic viral receptor by secreted gp70 SU may contribute to resistance to retroviral infection in these mice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627713      PMCID: PMC190016     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Authors:  R E Hussey; N E Richardson; M Kowalski; N R Brown; H C Chang; R F Siliciano; T Dorfman; B Walker; J Sodroski; E L Reinherz
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.

Authors:  M Kowalski; J Potz; L Basiripour; T Dorfman; W C Goh; E Terwilliger; A Dayton; C Rosen; W Haseltine; J Sodroski
Journal:  Science       Date:  1987-09-11       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research.

Authors:  R R Redfield; D L Birx; N Ketter; E Tramont; V Polonis; C Davis; J F Brundage; G Smith; S Johnson; A Fowler
Journal:  N Engl J Med       Date:  1991-06-13       Impact factor: 91.245

6.  A procedure for culture of cells from mouse tail biopsies: brief communication.

Authors:  M R Lander; B Moll; W P Rowe
Journal:  J Natl Cancer Inst       Date:  1978-02       Impact factor: 13.506

7.  Relationship between the oncornavirus gene product gp70 and a major protein secretion of the mouse genital tract.

Authors:  B C Del Villano; R A Lerner
Journal:  Nature       Date:  1976-02-12       Impact factor: 49.962

8.  Resistance to retroviral infection in transgenic and bone marrow chimeric mice containing Fv4-env-expressing hematopoietic cells.

Authors:  T Limjoco; A Nihrane; J Silver
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

9.  Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.

Authors:  M J Kadan; S Sturm; W F Anderson; M A Eglitis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Biological properties of a CD4 immunoadhesin.

Authors:  R A Byrn; J Mordenti; C Lucas; D Smith; S A Marsters; J S Johnson; P Cossum; S M Chamow; F M Wurm; T Gregory; J E Groopman; D J Capon
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

View more
  5 in total

1.  Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).

Authors:  A Nihrane; J Silver
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.

Authors:  H Ikeda; K Kato; T Suzuki; H Kitani; Y Matsubara; S Takase-Yoden; R Watanabe; M Kitagawa; S Aizawa
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Fv-4: identification of the defect in Env and the mechanism of resistance to ecotropic murine leukemia virus.

Authors:  G M Taylor; Y Gao; D A Sanders
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

4.  Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex.

Authors:  D J Opstelten; M Wallin; H Garoff
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

Review 5.  High-throughput insertional mutagenesis screens in mice to identify oncogenic networks.

Authors:  Jaap Kool; Anton Berns
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.